Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples